About usSign in
Status
INACTIVE
Global HQ
Seattle, Washington, United States
Countries of investment
  • USA and
Investment stages
  • Seed
  • Series A
  • Series B
  • Series C
  • -
Industries
  • Health Tech
  • Biotechnology
About
Biomatics Capital is a venture capital firm dedicated to transforming health care and medicine through strategic investments. The firm is at a tipping point where the convergence of genomics and digital data is enabling revolutionary advancements in therapeutics, diagnostics, and delivery models. Biomatics Capital has a savvy and nimble team with exceptional vision and execution capabilities ranging from gene editing to DNA synthesis. Their passion for groundbreaking technologies combined with their business acumen provides entrepreneurs with unparalleled support and a vital network of experts, driving the next generation of companies toward exceptional value and innovation.
Min check size
$5M
Max check size
$10M
Fund size
NPS

Investment Thesis

Biomatics Capital focuses on transforming health care and medicine through investments in breakthrough science, particularly at the convergence of genomics and digital data, which enables the development of superior therapeutics, diagnostics, and delivery models.
Lead investor
Co Invest
Number of exits
Preferred contact method

Team

Boris Nikolic

M.D. – Managing Director

Julie Sunderland – Cofounder

Errik Anderson – Venture Partner

Mike Poole

M.D. – Venture Partner

Yeon Cramer – Business Operations Manager

Portfolio

Denali Therapeutics

BlackThorn Therapeutics

Grail

Encodia

Omniome

Cytrellis

Verve

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp